Results Area 1 - PHC policy and standards defined to support implementation (US$24.025 million)

• DLI1 - The component will support the central MoH’s and the provincial authorities’ endorsement of policies, standards, and guidelines for reorganizing the PHC system
• DLI2 - The component will support the MoH’s adoption of clinical protocols for defined priority health conditions

Results Area 2 - PMCI capabilities and services strengthened for more comprehensive and quality care (US$52.15 million)

• DLI3 - The required PMCI capabilities for providing comprehensive and quality care services
  • Having at least 25 percent of the adult population in its defined empanelment area screened and stratified for risk factors
  • Having at least two trained medical officers and one nurse (public health) officer
  • Having minimum set of operational diagnostic equipment and tools
  • Having minimum availability of essential drugs and lab test capacity (on-site or through a networked/contracted pharmacy or laboratory)
  • Undergoing quarterly supportive supervision facilitated by a checklist to ensure adherence to national quality and safety standards
• DLI4 - Patient-friendly services that may be provided by PMCIs
  • The PMCI routinely provides NCD drugs through one-month supply blister packs
  • The PMCI has arrangements with laboratory services, including with private laboratories, where patients can drop off specimens and pick up results at the PMCI
  • The PMCI has an arrangement with pharmacies, including with private pharmacies, where patients can pick up prescriptions for publicly financed drugs free of charge
  • The PMCI has an operational appointment system (web-based, phone, and other) for patients to register specific appointment times

Results Area 3 - Support to personal health record system and improvement of the national procurement and supply chain system (US$35.0 million)

The first system is the development and scaling up of health information systems that will facilitate coordinated patient care using personal health records and eventually, a web-based referral network

The second system is the improved supply chain management system to ensure timely and efficient supply of drugs

• DLI5 - To support the process of patient empanelment and risk stratification, the component will support the adoption and rollout of a personal health record for use by the PMCI (DLI 5).
• DLI6 - To ensure that the drug supply at the facility level is based on demand, timely, and using the most economical procedures, the component will support improvement of the procurement and supply chain management system efficiency (DLI 6).

Results Area 4 - Development and implementation of a community engagement mechanism (US$25.80 million)

• DLI7 - The component will strengthen the community engagement mechanism and increase accountability for the health sector

Results Area 5 - Utilization of PHC services, with a focus on NCD detection and active follow-up, is increased (US$48.025 million)

• DLI8 - The component will support the MoH’s continued effort to screen women for cervical cancer, targeting women at age 35 and at age 45 years
• DLI 9 - The component will support the effort to identify and actively follow up with high risk adults for NCDs (according to the WHO standards for NCD risk stratification) at PMCIs